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Background: Previous studies have shown that unsafe injection practice is a major public health problem in Nepal
but did not quantify the problem. The present community-based study was planned to: 1) quantify injection usage, 2)
identify injection providers, 3) explore differences, if any, in injection usage and injection providers, and 4) study and
compare people’s knowledge and perception about injections between the urban and rural areas of Kaski district.
Methods: A descriptive, cross-sectional mixed-methods study was conducted from July to November 2012, using a
questionnaire based survey and focus group discussions (FGDs). A semi-structured questionnaire advocated by the
World Health Organization was modified and administered to household heads and injection receivers in selected
households and the FGDs were conducted using a topic guide. The district was divided into urban and rural areas and
300 households from each area were selected. Twenty FGDs were held.
Results: In 218 households (36.33%) [99 in urban and 119 in rural] one or more members received at least one
injection. During the three month recall period, 258 subjects (10.44%) reported receiving injection(s) with a median of
two injections. The average number of injections per person per year was calculated to be 2.37. Health care workers
(34.8%), staff of medical dispensaries (37.7%), physicians (25.2%), and traditional healers (2.3%) were consulted by the
respondents for their basic health care needs and for injections. Compared to urban respondents, more rural
respondents preferred injections for fever (p < 0.001). People preferred injections due to injections being perceived by
them as being powerful, fast-acting, and longer lasting than oral pills. More than 82% of respondents were aware of,
and named, at least one disease transmitted by using unsterile syringes during injection administration or when
syringes are shared between people.
Conclusions: Less preference for injections and high awareness about the association between injections and
injection-borne infections among the general population is encouraging for safe injection practice. However,
respondents were not aware of the importance of having qualified injection providers for safe injections and were
receiving injections from unqualified personnel.
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Injection is one of the many important health care pro-
cedures used worldwide in the allopathic system of
medicine. It is perceived by both prescribers and patients
as being one of the most powerful methods of restoring
or maintaining health, making it popular and sometimes
overused in developing countries [1-3]. The unsafe use* Correspondence: sudeshgy@hotmail.com
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unless otherwise stated.of injections, particularly reuse of injection devices with-
out proper sterilization, was high (almost 75%) in South
East Asia Region D which includes Nepal [2].
Various factors influence prescription and use of injec-
tions. The attitude of patients towards injections [4,5],
the qualification of injection providers, and the availabil-
ity of quality injections (with or without prescriptions)
and other equipment, have significant influence on injec-
tion use (popularity) [1,6]. Injection providers perceive
that injections are preferred by patients; its use elevates
their status and helps them to prove their professionall. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[7-9]. Various types of health care personnel with different
qualifications and training administer injections. These
personnel differ from place to place and time to time [10].
Studies [2,11] have reported that, in developing countries
including Nepal, significantly large numbers of injections
are given by untrained and unqualified health workers or
employees of government health care facilities [1]. In
Nepal there are no specific rules regarding the qualifica-
tion and training of injection providers [12].
Safe and unsafe injection practice
A safe injection is one that, “does not harm the recipient
(patient), does not expose the health care worker to any
risk and does not result in waste that is dangerous for
the community” [13]. Hence, the safety of an injection
should be evaluated with respect to these three aspects,
that is, safety of recipient, the injection provider, and the
community. The recipients of injections could be safe-
guarded by administering useful injections only (rational
prescription) with a new sterile single use device and
observing proper techniques by a qualified well-trained
health care worker [14,15].
The use of unnecessary and unsafe injections contrib-
utes to the transmission of a wide variety of blood-borne
pathogens, including viruses, bacteria, fungi and parasites
[16]. Among the infections transmitted through such
practice, Human immunodeficiency virus (HIV), Hepatitis
B virus (HBV) and Hepatitis C virus (HCV) are of special
concern as the social, economic, and disease burden re-
lated to these infections are high, the infections are pre-
ventable, and the treatment is very costly and often not
available to the people in need [17]. Unfortunately these
problems are overlooked in developing countries because
the immediate (acute) effects of unsafe injections are not
common and often go unnoticed [13,18].
Health care services in Nepal
Nepal is a developing country situated in the South East
Asia region, lying between two giants (India and China).
Health care services in Nepal are provided by both the
government and the private sector. Government delivers
its services through the organizational network of the
Department of Health Services (DoHS). A Sub Health
Post (SHP) is the first contact point for basic health care
services. Each level above the SHP is a referral point in
the network: from SHP to Health Posts (HP) to Primary
Health Care Centers (PHCC) to district, zonal & re-
gional hospitals and finally to tertiary care hospitals in
the capital of Nepal (Kathmandu). These units are man-
aged by trained health care workers [e.g. Auxiliary health
workers (AHW), Auxiliary Nursing midwifes (ANM),
Community Health Workers (CHW)], with medical doc-
tors and nursing staff stationed at PHCC and otherhigher level hospitals [19]. The AHW have either health
assistant (HA) or community medical auxiliary (CMA)
qualification. The HAs and CMAs undergo basic med-
ical training for 36 months and 18 months, respectively,
after completing 10 years of schooling. They are trained
to diagnose and treat common illnesses and refer pa-
tients for more specialized care if required [20,21].
ANMs obtain basic nursing training of 18 months after
10 years of schooling and assist in delivery of babies.
There are no compulsory injections that all citizens
and/or residents in Nepal have to take. Government of
Nepal provides free immunization services through rou-
tine and supplemental immunization programs [19]. The
government encourages the community to ensure that
all children up to the age of five are fully immunized
[19] but it has not been made mandatory to have these
vaccinations. Additionally, medical services provided by
private hospitals (nursing homes), private teaching hos-
pitals, private clinics, and missionary hospitals comple-
ment the government services [19].
Kaski district is one of the more advanced districts
and favorite tourist destinations of Nepal [22]. All types
of injections e.g. disposable syringe, cannula, prefilled
syringes, insulin syringe, insulin pen etc. are available in
the district. Except for a few narcotic injections, most
injections and injection equipments (e.g. syringe, can-
nula etc.) can be purchased even without a prescription
[21]. Insulin pen is also available in the district but is ex-
pensive. The type of injections available in a pharmacy,
and health facility depends on the nature of the facility
and its location.
A few studies related to injection practice in Nepal
[12,23,24] have shown that unsafe injection practice and
improper sharps management were a major public
health problem. These studies were conducted in health
care facilities, among health care workers (HCWs) and/
or patients visiting the health facilities and did not
quantify the problem at the population (community)
level. Furthermore, a small scale study [25] had recom-
mended a community-based survey to triangulate the
initiatives taken by the government of Nepal and obtain
a clearer picture of injection practices. The present
community-based study was planned to: 1) quantify in-
jection usage, 2) identify injection providers, 3) explore
differences, if any, in injection usage and injection pro-
viders among urban and rural areas, and 4) study and
compare people’s knowledge and perception about in-
jections between urban and rural areas of Kaski district.
Methods
Study design
A descriptive cross sectional study employing both quanti-
tative and qualitative research methods was conducted
from July to November 2012. The study consisted of two
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group discussions (FGDs) with the respondents.
The questionnaire was administered to household
heads and injection receiver/s (as explained later in the
methodology section) in each household. Respondents
who were willing to share their experiences and percep-
tions about diseases, therapy, and injection were invited
to participate in FGDs. The FGD was planned on the
same day or on the next day after the households’ survey
in a particular enumeration area (EA). A ward, the smal-
lest political division of the district with clear geograph-
ical boundaries, was considered as an EA.
Study area
The research work was carried out in Kaski district of
Nepal. For administrative purposes, the country is di-
vided into 75 districts, 3915 Village Development Com-
mittees (VDCs) and 58 municipalities [26]. Kaski district
is one of the 75 districts located in the Western region
which has 43 VDCs and 2 municipalities (Pokhara and
Lekhnath) [22]. The preliminary census report 2011
showed that the total population of the district was
490,429 [27].
Sample size and sampling technique
The sample size was calculated using the formula [28]:
Minimum sample size required (n) = 4pq/E2. Where ‘p’
(proportion of injection use), was calculated using the
data from the pilot study carried out in Baglung (adja-
cent to Kaski) district. The calculated p value was 37%
(0.37), q (1-p) was 0.63, and E (allowable error at 11%)
was 0.0407. Hence, the required number of minimum
households was calculated to be 563. Therefore, 600
households (300 from each stratum) were considered for
the study.
The sampling was done using stratified sampling
method dividing the district into two strata e.g. urban
and rural. The municipalities of the district were classi-
fied as urban while the VDCs were stratified as rural.
The total EAs (wards) in Kaski district were 420 and to
cover more than 10% of total EA, it was decided to take
50 EAs (25 from urban and 25 from rural) for the study.
Twelve households from each EA made a total of 300
households (25 EA × 12 households = 300 households).
All wards of VDCs were tabulated in the sequence as
recommended by the district statistics office and men-
tioned in the district profile, Kaski [22]. The total num-
ber of households in each ward was written in adjacent
columns of the table with cumulative total in the next
column. The sample interval was calculated by dividing
the total cumulative household in each stratum by 25
and a random number was generated using Excel 2013.
The first three digits after the decimal were considered
to be a random number. The ward corresponding to thehousehold of random number generated and the num-
bers obtained after every addition of sample interval
were selected for the study. In the sampled ward (EA),
one house was selected randomly then consecutive house-
holds were covered until 12 households were covered.
For the purposes of this study, an injection was de-
fined as “a skin-piercing event performed with a syringe
and/or needle with the purpose of introducing a curative
substance or a vaccine into a patient by various routes”
[29]. The study included all type of injections e.g. thera-
peutic bolus injections and infusions, immunizations etc.
Other skin-piercing events done using a needle e.g. to
transfuse blood, phlebotomy for diagnostic purposes, in-
jections for drug abuse etc. were excluded from the study.
Inclusion and exclusion criteria
Each household of Kaski district was considered a study
unit. People who shared the same kitchen for at least six
months were considered a family (household) [30]. Only
HH who may or may not have received injection/s and
the members of the family (household) who had received
at least one injection during the last three months were
considered for the survey. During the study period, there
was a national Measles Rubella (MR) vaccination cam-
paign in Kaski district. The MR vaccine administered
during the national vaccination campaign was excluded
from the study. People staying in Kaski for less than
6 months and children of age less than 6 months were
also excluded from the study. A non-resident Nepalese
family member who recently visited his/her family at
Kaski and was sharing kitchen for less than six months
was also not considered as a family member and was
excluded [30].
Data collection tools
Three data collection tools were used in the study: a
basic household information form, a semi-structured
questionnaire and a topic guide for FGDs (described in
the FGD subsection). These are described below.
The basic household information form
This was used to collect basic information from the
household head, e.g. age, gender, education, occupation,
injection event during the last three months etc. of all
the members of the household.
The questionnaire
The questionnaire used was based on the questionnaire
advocated by the WHO to assess and evaluate injection
practices [31]. The WHO advocated questionnaire was
standardized as per the context. The questions were dis-
cussed among the authors and experts in the field, some
questions were deleted, a few were modified, some were
reframed and restructured for better understanding, and
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lect information about exposure to mass media, their use
to obtain health related information, and about health fa-
cilities preferred by the community for basic health care
problems and injections were added. The questionnaire
thus constructed was modified by including suggestions
obtained during the pilot study and inputs from experts in
the subject. The modified questionnaire was forward
translated into Nepali (national) language by a group of
three individuals proficient in both languages. The ques-
tionnaire translated into Nepali was then provided to a
different group of three individuals proficient in both
languages for backward translation to English. The back-
ward translated English questionnaire was then compared
with the original questionnaire and discrepancies, if any,
were noted and analyzed. If required modifications to the
original questionnaire were carried out and the same was
finalized. The persons involved in the translation were not
involved in the study.
The finalized questionnaire consisted of a mixture of
structured close-ended and semi-structured open-ended
questions and could be divided into 5 parts: part one
collected information about the number of injections re-
ceived (both therapeutic and vaccine) in the last three
months; part two collected information about injection
providers, types of syringe used for the injections, where
the injection event took place and the money paid by
the recipient for the injection; part three collected infor-
mation about needle stick injuries (NSI); part four assessed
the respondents’ knowledge and perception about safe in-
jection practice, their preference of dosage form for fever
and of health facilities for minor illness and injections; and
part five collected information about exposure to mass
media like radio, television, internet and newspapers, and
use of these as sources of health information.
The pilot study was conducted during May and June 2012
in 60 households (10% of total sample size). The results of
the pilot study were not included in the main analysis.Descriptions and measurement of some variables
mentioned in the study
Age
Age was measured as years completed by a person in case
of an adult or months completed in case of infants (age
less than a year) at the time of the survey. The age was
classified into five groups: Infants (up to 1 year), Toddlers
(1–5 years), Children (5–14 years), adult (15–60 years)
and elderly (more than 60 years).Education
Central Bureau of Statistics (CBS) – Nepal states that a
person is literate if s/he is able to read and write with
understanding in any language and to perform simplearithmetic calculations [30]. In the study, people were
classified into two groups: Illiterate and Literate.
People who had learned to read and write through liter-
acy classes or at home were considered to be literate.
People who had gone to school were considered educated.
In terms of level of education, the respondents were clas-
sified into five groups: primary level completed (up to five
years of education), secondary level completed (ten years
or less), Higher secondary (up to 12 years of education),
Graduation and Post-graduation and above.
Prevalence of injection use at the household level
The prevalence of injection use at the household level
was calculated by as per the criteria mentioned by Staa
et al. [6]:
Prevalence = Number of households in which at least
one family member had received at least one injection in
the past three months/Total number of the households
considered for the study.
Frequency of injection use
Frequency of injection use was expressed as number of
injections per person per annum which was calculated
using the following formula [31]:
Number of injections per person per annum
¼ Total number of injections received in the last three months
Total number of participants of the survey
 4
Mass media exposure
Mass media exposure is a composite measure. It has
been shown that people who have been exposed to mass
media are more likely to know about HIV/AIDS, Sexu-
ally transmitted diseases and other health related issues
than those who are not exposed [32]. It was computed
based on whether the respondent listens to radio daily,
watches television daily, reads newspapers at least once
in a week and surfs internet at least once in a week. Ex-
posure to media was divided into four categories: ex-
posed to any one, exposed to any two, exposed to any
three and all four.
Data collection procedure
The survey
In each household, the head was asked the age, gender,
education, religion and occupation of all the family mem-
bers which was entered into the basic household informa-
tion form. The head and all the members (present at the
time of survey) were also asked whether they had received
any injection(s) during the last three months. The person
in a family (house) who makes health related decisions of
the family was considered as household head (HH) for the
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member of the family was consulted for the same.
The HH and the family members who had received at
least one injection during the past three months were
surveyed using the questionnaire in Nepali language.
When the injection receiver was less than 14 years or
could not communicate properly due to any disability,
the questions were asked to the parent (preferably
mother). In this group of injection receivers the ques-
tions from part one and two were only asked. The survey
was preferably conducted on Saturday (official weekly
holiday in Nepal) or in the evening, so that a maximum
number of family members were present.
The FGDs
Conceptualization The topics to be addressed during
the FGD were conceptualized following a thorough lit-
erature review and discussion among the authors of this
study and with inputs from experts in this field.
Creating the FGD guide The topic guide was prepared
by conducting a thorough literature review and explored
certain issues which were noted during the survey in
more detail. The guide covered a range of issues: popula-
tion perspectives about illnesses and its treatment; role of
injections in therapy; population preferences for injec-
tions; and knowledge about safe/unsafe injection practice.
Logistics and facilitation A final year student of Bach-
elor of Pharmacy course was trained as a note taker. The
note taker was responsible to take down hand written
notes and observations (nonverbal behavior) during the
FGDs. He was also responsible for audio recording when
the discussions were recorded. The discussions were fa-
cilitated by SG (corresponding author of the manuscript)
with experience of qualitative research and were held
under the guidance of VKKC (coauthor).
Members eager to share their opinion and able to ex-
press their view fluently (in Nepali) were selected and
requested to participate in FGDs. The discussions were
conducted as per the convenience of the participants
preferably during early or late afternoon. FGDs were
conducted to get additional information regarding cer-
tain responses in the questionnaire (reasons for their
practice/response) and covered the range of issues men-
tioned previously. Twenty (10 from urban and 10 from
rural area) FGDs were conducted in different EAs. FGDs
were held with 6–8 household members (age more than
15 years) from different households. A total of 147 par-
ticipants participated in the twenty FGDs. The discus-
sions were held for about 60–90 minutes without any
break. The FGDs were conducted in Nepali language.
Most FGDs were audio recorded while hand-written
notes were also taken during some depending on thechoice and consent of the participants. Immediately after
the FGD, the facilitator along with the note taker checked
and discussed the completeness of the notes.
Analysis and reporting The qualitative data obtained
from FGDs were coded and analyzed using deductive
content analysis [33,34] where literature review and the
FGD guides were used to develop categories and subcat-
egories for coding and analysis. Audio recordings were
transcribed in Nepali. The transcript was then translated
into English by a person fluent in both languages and
not associated with the study. Each transcript was read
through several times to obtain a sense of the whole. All
words, sentences and paragraphs containing aspects re-
lated to each other through their content were then
coded for correspondence with predetermined categor-
ies. Additional information provided by the respondent
was placed in a different new category if required. Direct
quotes were contextualized, rendered readable and pre-
sented in the habitual language of the respondents. Fi-
nally, the quotes were translated from Nepali to English.
Ethical issues
The study protocol was approved by the ethical review
board of Nepal Health Research Council, Kathmandu,
Nepal. The participants were explained about the study
and were assured about the confidentiality of informa-
tion given by them. Participants were given a clear op-
tion not to take part if they wished to do so. Informed
verbal consent was obtained prior to the study. The con-
sent for study subjects who were less than 14 years of
age or could not communicate properly due to disability
was taken from the accompanying parent (preferably the
mother).
Data analysis
All quantitative data was coded and entered into com-
puter software programs Statistical Package for Social
Sciences (SPSS) version 17.0 for Windows and Microsoft
Excel 13 for statistical analysis. The data was presented
as mean, median, inter-quartile range and standard devi-
ation (SD) for continuous variables such as age, number
of injections received etc. Frequency and percentage (%)
of various variables were calculated for categorical vari-
ables like gender and incidence of NSI. Data from urban
and rural areas were compared and Pearson chi-square
test was done to check for significant relations. A p-
value of <0.05 was considered as statistically significant.
Results
The survey covered 2470 people (family members) in
600 households sampled. The mean ± SD family mem-
bers in a household were 4.12 ± 1.75. The overall male:
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areas was 0.89 and 0.94, respectively.
In the urban areas surveyed, 1196 family members
were present in 300 households whereas in rural areas
1274 members were present in 300 households. Table 1
shows the comparative demographic characteristics of
the urban and rural population in our survey.
Injection use
Out of 600 households, in 218 (36.33%) [99 (33%) in
urban and 119 (39.67%) in rural] of the households one
or more members received at least one injection during
the preceding three months. During the period, 258
(10.44%) of the subjects in the survey reported having
received injection(s). One hundred and thirteen persons
(9.45%, n = 1196) from urban areas and 145 persons
(11.38%, n = 1274) from rural areas received at least one
injection. The most frequently used single dose injection
was Tetanus toxoid (TT) injection followed by long-
acting (three months) contraceptive injection. Median
number of injections received by the respondents was 2
with an inter quartile range of 2. The median (IQR)
number of injections received by respondents in urbanTable 1 Comparison of demographic characteristics of the su
Characteristics Urban population
n = 1196 (%)
Gender Female 632 (52.84)
Male 564 (47.14)
Age in years <1 3 (0.25)
1 to 4 50 (4.18)
5 to14 214 (17.89)
15 to 60 849 (70.99)
>60 80 (6.69)
Literacy Illiterate 86 (7.19)
Literate 1090 (91.14)
Not applicable** 20 (1.67)
Education Primary 186 (15.55)
Secondary 353 (29.52)
Higher secondary 170 (14.21)
Graduation 218 (18.23)
Post-graduation 82 (6.86)
Occupation Farming 68 (6.00)
Student 470 (41.45)
Housewife/ unemployed 190 (16.75)
Business 166 (14.64)
Private employee 124 (10.93)
Government employee 81 (7.14)
Others 35 (3.09)
*Chi-square & p values (two-sided) were calculated by Pearson chi-square test, **Childr
not applicable to them.and rural areas was 1 (2) and 2 (2), respectively. The
total number of injections used in the last three months
by the sampled population was 1462 injections. Hence,
the average number of injections per person per year
was calculated to be 2.37.
Out of 1462 injections, only 42 (2.87%) were vaccines.
The mean (± SD) age of injection receivers was 32.99
(±21.55) years. Table 2 shows injections were most com-
monly used in children age less than 5 years and elderly
people of age more than 60 years.
Obtaining medical help
All HHs were asked, “Where and whom do you consult
for your (families’) basic health care needs?” Health care
workers (HCWs) at government health care facilities or
at their clinics (34.8%), staff of medical dispensaries
(37.7%), physician (25.2%), and traditional healers (2.3%)
were consulted by the respondents for their basic health
care needs and for injections. More than half (57.7%) of
the respondents from rural areas stated that they pre-
ferred to consult HCWs, followed by staff of medical
dispensaries (22.3%), for their health care needs and in-
jection while 53% of urban respondents preferred staff ofrveyed respondents
Rural population
n = 1274 (%)
Total population
n = 2470 (%)
*Chi-square (p) value
658 (51.65) 1290 (52.23) 0.353 (>0.05)
616 (48.35) 1180 (47.77)
10 (0.78) 13 (0.53) 20.935 (<0.001)
61 (4.79) 111 (4.49)
222 (17.43) 436 (17.65)
837 (65.70) 1686 (68.26)
144 (11.30) 224 (9.07)
179 (14.05) 265 (10.73) 41.922 (<0.001)
1048 (82.26) 2138 (86.56)
47 (3.69) 67 (2.71)
257 (20.17) 443 (23.46) 114.750 (<0.001)
405 (31.79) 758 (40.15)
109 (8.56) 279 (14.78)
91 (7.14) 309 (16.37)
17 (1.33) 99 (5.24)
305 (25.50) 373 (16.01) 271.983 (<0.001)
462 (38.63) 932 (40.00)
235 (19.65) 425 (18.24)
57 (4.77) 223 (9.57)
48 (4.01) 172 (7.38)
29 (2.42) 110 (4.72)
60 (5.02) 95 (4.08)
en of age less than or equal to three years are not sent to school so literacy was
Table 2 Percentage of injection receivers classified
according to age and place of residence
S. No. Age in years Percentage of population receiving
injection
Urban area (n) Rural area (n) Total (n)
1. Less than 1 66.67 (3) 100.00 (10) 92.30 (13)
2. 1 to 4 16.00 (50) 11.47 (61) 13.51 (111)
3. 5 to 14 5.14 (214) 3.60 (222) 4.36 (436)
4. 15 to 60 9.42 (849) 12.19 (837) 10.79 (1686)
5. More than 60 15.00 (80) 12.5 (144) 13.39 (224)
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nificantly (p < 0.001), higher number of rural respon-
dents (4.3%) also preferred to consult traditional healers
for basic health care need and for injections.
Demographic characteristics of the people included in the
detailed study of injection practice
To study the details of injection practice (including
knowledge and perception of people towards injection
practice), household heads and injection receivers aged
15 years and above were included. A total of 714 (354
from urban and 360 from rural) respondents satisfied
the inclusion criteria and were included in the study.
The mean (±SD) age of the respondents was 43.78
(±15.80) years with a range of 15 to 89 years.
In each household, information about all the family
members was collected using the basic householdTable 3 Percentage of respondents classified by place of resid
Characteristics Urban, frequency (%), n = 354 Rur
Gender Male 213 (60.17) 206
Female 141 (39.84) 154
No. of respondents who received
injections in last 3 months**.
92 (25.99) 119
Literacy Literate 324 (91.53) 294
Illiterate 30 (8.47) 66
Education# Primary 7 (2.43) 50
Secondary 108 (37.50) 110
Higher secondary 62 (21.53) 28
Graduation 66 (22.91) 22
Post-graduation 45 (15.63) 4 (1
Occupation Farming 28 (8.14) 166
Student 26 (7.56) 12
Housewife/unemployed 65 (18.89) 70
Business 96 (27.91) 41
Private employee 54 (15.70) 13
Government employee 52 (15.12) 13
Others 23 (6.68) 37
*Chi-square and p value (two-sided) were calculated by Pearson chi-square test compa
#The percentage was adjusted as per the number of literate in the respective groups.information form (Refer to Additional file 1). In 600
households, a total of 2470 family members were present;
information about the household members is presented in
Table 1. Out of the 2470, 258 received injections dur-
ing the last three months recall period which included
children and adults (>15 years of age). The question-
naire was administered to all 258 injection receivers.
Injection receivers less than 14 years of age were ad-
ministered part1 and 2 of the questionnaire and the in-
formation was collected from the parent (preferably
the mother).
The questionnaire was also administered to household
heads (HHs) who may or may not have received injec-
tion during the last three months. The household heads
who received injection were requested to answer all
questions while among the heads who did not receive in-
jections part 1 of the questionnaire was excluded. The
demographic information relating to household heads
and injection receivers aged more than 15 years are pre-
sented in Table 3. The heads and injection receivers
(>15 years of age) who were willing to share their experi-
ence and opinion were selected for FGDs.
Out of 714 respondents, 618 (86.55%) were literate
and the difference in literacy among urban and the rural
population was highly significant (p < 0.001). Out of 618
literate people, 502 (81.22%) had formal education. The
number of people having formal education and level of
the education achieved were also significantly different
(p < 0.001) in urban and rural areas (Table 3).ence according to selected demographic characteristics
al, frequency (%), n = 360 Total (%), n = 714 *Chi-square (p) value
(57.22) 419 (58.68) 0.639 (0.424)
(42.78) 295 (41.32)
(33.06) 211 (29.55) 4.282 (0.039)
(81.67) 618 (86.55) 14.907 (<0.001)
(18.33) 96 (13.45)
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All respondents (714) were asked to recall the details of
the injection provider and venue where they received
the last injection (without any time limit). Out of 714 re-
spondents, 458 (64.15%) could remember the last injec-
tion received. Approximately 70% (247/354) of the
urban area respondents and 59% (211/360) of the rural
area respondents could recall the last injection event.
Table 4 shows the injection providers and venue of the
injection event as recalled by the respondents. Formal
sector (doctor, nurse, HA, CMA, AHW etc.) who are
trained and have the legal right to provide injections,
were most commonly consulted for injections followed
by persons working in medical dispensaries. As HA,
CMA, and AHW were identified as ‘a doctor’ by many
respondents, all of them were included in the formal
sector in our study.
Type of syringe used to administer injections
Most (94.76%) respondents reported that a single use
disposable syringe was used for administering injection
and the syringe was taken from a sealed packet. A few
(4.37%) of the respondents could not recall the type of
syringe used. The proportion of respondents reporting
the use of sealed-packed, disposable syringes was similar
(p = 0.424) in urban and rural areas.
Injection administration service charge
Almost half the injection receivers and household
heads from urban and rural areas who could remem-
ber the last injection events reported that they were
not aware of the service charge they paid for injection
as the charge was either added along with injection
equipment and medicine costs or taken in the form of
commodities. The percentage of people unaware about
the service charge were higher in urban areas than rural
and the difference was statistically significant (p < 0.001).
Almost a quarter of the respondents said that theyTable 4 Injection providers and venue of injection events
Characteristics Urban, n = 247 frequency (%) Ru
Injection providers Formal sector 171 (69.23) 18
Medical dispenser 68 (27.53) 30
Relative 4 (1.62) 0 (






Clinic 35 (14.17) 23
Medical Shop 75 (30.36) 38
Home 9 (3.64) 2 (
School** 2 (0.81) 5 (
*Chi-square and p value (two-sided) were calculated by Pearson chi-square test compa
were also used as a vaccination venue.received the injection free of cost while another quar-
ter of respondents could not remember the cost. As
the people in rural areas rely more on government
health facilities where the services were provided free
of cost, fewer people in rural areas reported paying
service charge for injection administration compared
to urban areas.
Incidence of needle stick injury (NSI)
Among the 714 respondents, 19 (2.66%) reported that
they had suffered a NSI through an injection needle in
the garbage or in the environment. Of these, 13 (68.42%)
and 6 (31.58%) were from urban and rural area respect-
ively. Some respondents had sustained the injury while
swimming in a river, implying that used syringes might
have been disposed of in rivers.
People’s perception about injections
When the 714 respondents were asked to name the dosage
form they preferred for fever, 564 (79%) said they would
prefer oral dosage form like tablet or capsules. In compari-
son, 5% of respondents preferred injection/intravenous
fluid and 16% of respondents shared that they have no par-
ticular preference. More rural respondents (7.8% rural Vs
2.3% urban) preferred injections while more urban respon-
dents (90.1% urban Vs 68.1% rural) preferred oral pills for
fever and this difference was found to be highly significant
statistically (chi square = 63.440, p <0.001).
The reasons given for preferring oral pills over injections
were: oral is easy to take (43.1%), an injection is painful/ I
am scared of an injection (12.5%), oral pills have less side
effects (13.5%), others (15.1%), and do not know (15.8%).
A significant number of people preferred oral pills
because of fear of injections.
“Once we use injection for fever, we become addicted.
It will have to be repeated every time we then have
fever.” [Rural Female (RF)-19-5/8]ral, n = 211 frequency (%) Total (%), n = 458 *Chi-square (p) value









ring urban and rural frequencies; **During national vaccination programs, schools
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not work next time & injection becomes must for
future……” [Urban Female (UF)-25-7/2]
During FGDs it was found that people had a perception
that injection is powerful and should be used in severe
(serious) illness only.
“Injection is for malaria (severe disease) only…. not for
general fever.” [Rural Male (RM)-52-7/5]“Pills are generally prescribed for fever so we take
them….. Injection is preferred when there is big fever or
patient is admitted in a hospital……” [Urban Male
(UM)-35-1/6]“When we (the village people) fall sick…. we use
medicinal herbs (easily available) or go to traditional
healers first and continue our work… Until we become
very serious we don’t go to hospitals. When we go to
hospital that means, we are very serious and pills will
not work…we need some powerful medicines… Yes
Injections…” RM-54-1/8
Respondents’ perception about the seriousness of disease
were duration of illness (time taken to be cured), response
to the oral therapy (in serious diseases oral pills are inef-
fective and injections are used), and actions taken during
and as a result of the illness (e.g. admission to the hospital,
failing to perform normal duty or taking to bed at home).
Around 6% of the respondents believed that injections
are a must for them because they thought that their ex-
pectations will be fulfilled only by injections or that they
were dependent on injections. Some of the typical ex-
pectations or reasons for their preference for injections
were as follows:
“I always suffer from high (severe type) fever… hence
injection is a must for me….” RM-59-2/6“Medical [dispenser] hesitate to give injection in fever.
But I need saline (IV fluid) for fever…. because it cools
[my] body and blood…” RM-56-3/5“…I am addicted to saline (IV fluids), every summer I
have to take few bottles [of IV fluids] to feel good for
the whole year” RF-62-2/8
Few respondents also reported that they prefer injec-
tions because they have a perception that injections are
longer acting than pills. One female respondent said,
“Swallowing of tablet is difficult and it is bitter too, so I
prefer Injection. Injection also acts for longer periods of
time… See contraceptive pills have to be taken daily whileinjectable contraceptive works for three months” UF-40-2/
8. In Nepal, injectable contraceptives (depot preparation)
which work for three months are a popular choice.
During the survey, 114 (16%) respondents (as men-
tioned above) said they have no particular preference for
a dosage form in fever and would accept whatever their
health care professionals prescribed. Some of the com-
mon responses were:
“It is the quality of medicine which counts, not the
injection or pill … So anything (pill or injection) is ok,
provided they are of quality” UM-54-3/2
Despite the reasons reported above, some people re-
ported avoiding injections to prevent complications (risks)
associated with injections.
“Injections transmit diseases…So I avoid injection even
a TT (Tetanus Toxoid injection) …” RM-42-4/3“We don’t know what type of syringe is being used…
dirty syringe cause adverse effects…… I prefer
tablets…” RM-57-5/4“The injection stored improperly may not work. It
requires very good storage condition which tables do
not require. Tablets always work…so tablets are
better.” UM-37-4/7
Knowledge about safe injection practice
Most respondents (more than 90%) were aware that dis-
eases may be transmitted when unsterile syringe is used
for administering injections or when the same syringe is
used to administer injections to more than one person.
Table 5 shows that urban respondents were more aware
about unsafe injection practice than rural respondents.
Some typical responses shared during the FGDs were:
“Injection should be taken from qualified doctor or
nurse…… Nowadays a lot of quacks practice
(administer injections)…… so [it is] difficult to identify
who is qualified… One person from our village
received injection for one disease and became infected
with another disease (transmitted other disease)……”
RF-69-3/7
In some cultures, family members share clothing and
take food from the same plate. But they avoid sharing
the same with a person outside their family. They may
think that sharing the same syringe between family
members is acceptable but it should not be shared with
people outside the family. To differentiate this, the two
statements (marked as $) in Table 5 were asked separ-
ately. Table 5 shows that most (92.16%) of the people
Table 5 Respondents’ knowledge about safe injection practice
Issues Urban frequency (%) Rural frequency (%) Total (%) *α2 (p) value
Unsterile syringe can transmit diseases Yes 345 (97.46) 314 (87.22) 659 (92.30) 26.410 (<0.001)
No 0 (0.00) 1 (0.28) 1 (0.14)
Don’t know 9 (2.54) 45 (12.50) 54 (7.56)
Sharing syringe can transmit diseases$ Yes 341 (96.33) 317 (88.06) 658 (92.16) 16.920 (<0.001)
No 1 (0.28) 4 (1.11) 5 (0.70)
Don’t know 12 (3.39) 39 (10.83) 51 (7.14)
Sharing syringe between family members
also transmit diseases$
Yes 326 (95.60) 304 (95.90) 630 (95.74) 0.653 (>0.05)
No 8 (2.35) 5 (1.58) 13 (1.98)
Don’t know 7 (2.05) 8 (2.52) 15 (2.28)
*Chi-square & p value (two-sided) were calculated by Pearson chi-square test.
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two persons and not even between family members.
“…… previously syringes were reused but nowadays it
is said (HCW and Radio) that it (syringe) should be
used only for one person [single person]….” UF-71-5/8“… the breath of people differs from person to person
… Even sharing clothes or jutho (sharing food from
the same plate) will transfer diseases, then why not
syringe. Yeah… of course sharing same injection will
transfer diseases……” UM-69-8/3
Among the 659 respondents who stated that diseases
are transmitted by the use of unsterile syringes, 541
(82.09%) could name one or more diseases transmitted
by administering injections using unsterile syringes.
The percentage of respondents naming one, two, three,
four, and five or more correct diseases were 45.1%,
24.1%, 10%, 2.3%, and 0.61% respectively. Urban respon-
dents who were able to name a greater number of diseases
transmitted by the use of unsterile syringes, were sig-
nificantly higher (p < 0.001) than respondents from rural
stratum.Table 6 Peoples’ knowledge about diseases that might be tra
Disease transmitted# Urban, n = 345 frequency (%) Rural, n =
HIV/ AIDS 291 (84.35) 221 (70.38
Hepatitis/ Jaundice 77 (22.32) 14 (4.46)
Tetanus 62 (17.97) 25 (7.96)
Tuberculosis 40 (11.59) 29 (9.24)
Malaria 14 (4.06) 12 (3.82)
Hepatitis B 10 (2.90) 1 (0.32)
Hepatitis C 3 (0.87) 0 (0.00)
Other diseases 53 (15.36) 13 (4.14)
#The question was multiple response so the total is more than 100%; *Chi-square and
and rural frequencies.Most respondents (77.69%) named HIV/AIDS as one
of the diseases transmitted by the use of unsterile syrin-
ges (Table 6).Access to mass media and their use for health information
Radio, Television, Internet, and Newspaper were access-
ible to 57%, 81.5%, 21.0%, and 44.1% of respondents, re-
spectively. People in urban areas had significantly more
mass media accessible to them compared with those in
rural areas.
Mass media are an important source of health related
information. Out of the 714, 553 (77.45%) respondents
reported that they depend on at least one mass medium
to get health related information. Tendency to use media
for health related information was more in urban popu-
lation compared to rural population. Approximately 91%
(322/345) and 64% (231/360) of respondents from urban
and rural areas respectively, depended on at least one
mass media for health related information. Most respon-
dents (almost 66%) from urban area were using two or
more media sources for health related information while
48% of rural respondents were fortunate to have access
to the same (p < 0.001).nsmitted through unsterile syringes
314 frequency (%) Total (%) n = 659 *Chi-square (p) value
) 512 (77.69) 18.500 (<0.001)
91 (13.81) 44.057 (<0.001)
87 (13.20) 14.372 (<0.001)
69 (10.47) 0.975 (>0.05)
26 (3.95) 0.024 (>0.05)
11 (1.67) 6.667 (<0.05)
3 (0.46) 2.743 (>0.05)
66 (21.02) 22.972 (<0.001)
p value (two-sided) were calculated by Pearson chi-square test comparing urban
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health related information by the respondents and 77%
of respondents (83% urban Vs 69% rural, p < 0.001) used
television as a source of health information.
Discussion
In the present study in at least one out of three house-
holds, one or more members received at least one injec-
tion during the last three months and 10% of the sampled
population received injection/s during the last three
months. The injection use was more in rural population
compared to urban.
Injection use
The overall frequency of injections in our study was 2.37
injections per person per annum. This is more than that
reported in African (2.0 – 2.2), American (1.7 – 1.9) and
South East Asian B (2.1) regions [2] but is less than that
reported in an Indian study (2.9) [35], and South East
Asia Region D (4.0), including Nepal [2]. The injection
frequency is half of that observed in Cambodia (5.9) [36].
A high proportion (97.13%) of injections used in Kaski
district were given for therapeutic reasons which is simi-
lar to the global data, (95%) [3] but greater than the data
from India (82.7%) [35]. Health care facilities visited for
basic health care needs by the people in urban and rural
areas were significantly different. Government primary
health care facilities or clinics of the HCWs working at
those facilities were mostly preferred by rural people
while medical dispensary was preferred by urban people.
The medical dispensaries (community pharmacies) were
preferred by the community because a variety of medi-
cines [20] and services [21] were available at the dis-
pensaries, and people found them to be cheaper [20,37].
As both health care facilities (government health care fa-
cilities and medical dispensaries) were rarely supported
by laboratory investigations, in most cases the diagnosis
and treatment was based on only clinical presentation
which may not be an ideal situation. This highlights a
need for a Standard Treatment Guideline/Strategies for
common illness in primary health care facilities, how-
ever, the Standard Treatment Strategies in Nepal has not
been revised since 1999 [38].
Injection providers and venue
People reported that both the formal sector [including
doctor, nurse and other paramedicals (HA, CMA, ANM
etc.)] and informal sector (e.g. Ayurvedic HCWs, Medical
dispensers and pharmacists) were consulted for medical
problems and they received injections from the providers
as well. As injection use provides financial rewards and
status to providers [7,29], the informal sectors may have
been attracted towards injection use because they have
less status and money compared to physicians. Theinformal sector is neither qualified nor formally trained
for injection administration hence the injection provided
by them may be neither safe nor rational [29].
Implementation of interventions for safe injection in the
formal health care system is easier because it is under the
direct control of the government. The challenges increase
if injections are provided outside the formal health care
system [1]. As more people in urban areas in our study re-
ceived injections from medical dispensaries (outside the
formal health care system) than the rural population, in-
terventions promoting safe injection practice might be
more challenging in urban than in rural areas.
Almost a quarter of respondents in our study received
their injections at medical dispensaries which was similar
to the results of a study from Pokhara city [21]. The study
done by Gyawali et al. in 2012 at community pharmacies
of Pokhara city showed that the pharmacies (dispensaries)
were not well equipped and most working manpower of
the pharmacies were neither qualified nor trained for in-
jection practices [21]. Furthermore, in our study we found
that medical dispensers were considered as doctors and
people preferred consulting them for treatment of
minor illness. The injections administered by these un-
qualified personnel might be unsafe and non-rational
[29] but these personnel could be influenced by the gov-
ernment for safe injection practice.
A qualitative study conducted in central Nepal [23] re-
ported that grocery shops were also used as the venue
for injections but in our study this was not reported.
Similarly, a wide variety of venues including public
schools, teashops, and temples were reported to be used
for immunization in Nepal [12]. As schools are also
used as immunization venue for national immunization
program in Nepal [19], the schools were reported as a
venue in our study as well.
Needle Stick injury (NSI) caused by improperly disposed
of syringes
Safe disposal of used injection equipment is vital to pro-
mote safe injection practice. Unsafe disposal of sharps
(used injection equipment) exposes the community to
needle stick injury (NSIs) [39]. A few respondents (2.66%)
in our study reported that they were injured by an injec-
tion needle in the garbage or in the environment. This
proportion is more than that reported in a study based in
Pakistan (0.2%) [31].
Knowledge and perception about injection practice
It was found that the knowledge about injection practice
was better among urban dwellers than rural ones. Con-
sistent with the finding from a previous study among
health policymakers [25], almost all injection receivers
(94.76%) who recalled the last injection event reported
that plastic syringes taken from a sealed packet were
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tients did not know whether the needle and syringe used
to inject them were sterile [40]. This may indicate that
the people of Kaski were aware and consciously checked
the quality of the syringe (new syringe taken from sealed
pack) used. Empowering the community to question the
need for an injection and whether the syringe being used
was new, can have a meaningful impact in improving in-
jection safety [41], as using sterile syringe for adminis-
tering rational injection is important for the safety of
injection recipients [10,15]. Unfortunately, the quality
of the injection equipment available in Nepal is not
monitored [25] so the quality of the equipment may not
be assured.
In our study, fever was used as the condition to study
the preference for dosage form (oral or injection) be-
cause the illness could be described accurately using
local terms and it is also an illnesses which is either self-
limiting or could be treated by oral therapy. The respon-
dents shared that they preferred oral pills because the
pills were easy to administer, not painful and safe (no
additional side effects like injection). The respondents in
our study do not prefer injections because they had a
perception that injection produces dependence i.e. if an
injection is used for an illness, the next time when a per-
son gets similar illness oral pills may not work and injec-
tion becomes necessary.
Most respondents in our study had a perception that
injections are powerful and should be used only in se-
vere cases (major illness), in weak patients, and/or when
oral pill is not effective. They also had a perception that
fever is generally a minor illness so pills are sufficient
and injections are not required. The incidences of dis-
eases such as encephalitis, malaria, kala-azar and den-
gue, which are fatal and produce fever as a symptom are
either low or absent in Kaski district [19]. This may be
one reason why fever was considered as a minor illness.
However, the incidence of such diseases is more frequent
in the Terai region [19] so the perception of fever among
people from that region might be different. Hence, the
results should be extrapolated with caution to the Terai
region of the country.
A study from Pakistan showed that majority of com-
munity participants [82% (n = 249)] preferred injections
[41]. But in our study, only 5% preferred injection. The
proportion of people preferring injection in our study
was almost the same as the global data (5%) [29] and less
compared to a study from Pakistan [40] where 44% of
patients preferred injectable medicine. Global data show
that injections are preferred because they are thought to
be powerful, fast acting, latest technology and other rea-
sons [7,29,35]. The few respondents in our study who
preferred injection did so because they thought injections
are longer acting than oral pills or they are dependent onthe injection. This might because of their perception
about injectable contraceptives (depot preparation) which
work for three months and also due to the placebo feeling
of wellbeing for few months after receiving IVF. Few of
the respondents (16%) also reported that they would like
to leave decisions about the dosage form to HCWs which
was similar to a recent Pakistani study where almost 18%
of patients left the decision to prescribers [41].
More respondents in rural areas preferred injection
compared to urban (7.8% rural Vs 2.3% urban). This
might have influenced use of injections; hence number
of people receiving injection and use of injection were
higher in rural compared to urban respondents.
More than three quarters of the respondents were
aware and could name at least one correct disease that
may be transmitted when unsterile (dirty) syringe is used
for administering injections or when a syringe is shared
to administer medicine to more than one person. Higher
number of respondents from urban area (90.16%) than
rural respondents (73.25%) could name one or more dis-
eases transmitted by such practice. This might be due to
the communication of the risk of HIV infections associ-
ated with injection through HIV/AIDS prevention and
care programs as mentioned by the health policymakers
of Nepal [25]. Some of the respondents had a perception
that sharing the same syringe between two or more per-
sons other than family members may transmit diseases
but not if shared among family members. They were of
the opinion that all family members had a similar struc-
ture, physiology and even diseases. This perception was
similar among both urban and rural dwellers.
Most respondents (82%) had access to television
followed by radio and newspaper and these media in
the same sequence were used as sources for health re-
lated information. Similar response was also reported
in Pakistan where 79% of respondents reported that
television was the important community source for
health information [41]. Television and radio could be
used more extensively to provide information (educat-
ing population) about safe injection practice to people
of remote areas.
Significantly higher literacy rate, accessibility to mul-
tiple mass media and tendency to use the media as a
source of health related information in urban respon-
dents compared to rural ones might have increased
awareness and knowledge about safe injection practice
among urban respondents. Good awareness about the
association between injections and infections among the
general population may lead to demand for safe injec-
tions by the community. The awareness also leads to a
demand for use of sterile injection equipment (syringes)
for injections. As the people were aware of single use of
syringe and had some knowledge about the diseases trans-
mitted through unsterile syringes, it could be postulated
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of sterilization in Kaski which ultimately may lead to safe
injection practices. However, receiving injection from un-
qualified personnel at venues lacking facility for the injec-
tion could lead to unsafe injection practice.Strengths of the study
Injection use studies conducted among patients visiting
or admitted in health care facilities may report the injec-
tions administered by formal providers (mostly qualified
and trained) only. The present study has quantified the
injection use in the community and could be considered
as reliable data because it included all injections admin-
istered at all types of health care facilities (primary, sec-
ondary, tertiary etc.), at home and in other places by all
types of providers (formal, informal, quacks and self ).
This study has identified different types of injection
providers (qualified/trained, unqualified/untrained and
quacks) prescribing and administering injections to the
community. The results of this study may serve as the
baseline for conducting studies in the community regard-
ing injection usage in other districts and the western de-
velopment region of Nepal.Limitations of the study
The study was carried out in one of the hill districts of
the country so the results may not represent other non-
hill regions because the disease patterns, peoples’ per-
ception towards common diseases & injection efficacy,
access to health care facilities, burden of illness etc. may
differ. As the FGD participants were not selected ran-
domly and very few females participated, the qualitative
data from FGDs may not be representative if considered
alone. Hence, the qualitative results should be consid-
ered along with the quantitative results. Checking of the
transcript by the FGD participants could not be done
because of time constraints. All the FGDs were not re-
corded. As with all survey questionnaires, participant re-
call bias may have occurred.Conclusion
Use of disposable equipment, less preference for injec-
tions by the people, and high awareness about the asso-
ciation between injections and injection borne infections
among the study population is encouraging with regard
to safe injection practice. In urban areas, there was a
greater awareness of safe injection practice and the use
of and preference for injections was lesser compared to
rural areas. Unfortunately, people were not aware of the
importance of qualified injection providers for safe in-
jections and were receiving injections from unqualified
personnel. The number of people receiving injection frominformal providers was more in urban compared to rural
area.
Recommendations
As unsafe injection practices result in a substantial bur-
den of preventable blood-borne diseases, assuring safe
injection practice in developing countries is important.
Empowering the community to enquire about the ra-
tionality of an injection and demand for safe injections
could be vital in producing improvement in the situation.
Awareness about the importance of obtaining injections
only from qualified providers should be increased. Simi-
larly, monitoring the quality of the injection equipment
available in Nepal is also needed. Interventions to improve
injection practice may be more challenging in urban com-
pared to rural areas because more urban residents receive
injections from the informal sector. Further research to
identify the injection types and its quantity administered
by informal sectors is also required to increase the effect-
iveness of future interventions.
Additional file
Additional file 1: Basic Household Information Form.
Abbreviations
AHW: Auxiliary Health Workers; ANM: Auxiliary Nursing Midwifes;
CHW: Community Health Workers; CMA: Community Medical Auxiliary;
DoHS: Department of Health Services; EA: Enumeration Area; FGD: Focus
Group Discussion; HA: Health Assistant; HBV: Hepatitis B Virus; HCV: Hepatitis
C Virus; HCW: Health Care Worker; HH: Household Head; HIV: Human
Immunodeficiency Virus; HP: Health Post; NSI: Needle Stick Injury;
PHCC: Primary Health Care Centers; RF: Rural Female; RM: Rural Male;
SHP: Sub Health Post; UF: Urban Female; UM: Urban Male; VDC: Village
Development Committee; WHO: World Health Organization.
Competing interest
All the authors declare that they have no competing interests.
Authors’ contributions
SG, DSR, PRS and VVKC conceived and designed the study. SG collected
data. SG, MM, NJ and VKKC analyzed data and drafted the manuscript. DSR
and PRS helped to interpret findings and review drafts of the manuscript.
The final manuscript has been read and approved by all the authors.
Acknowledgements
The authors wish to thank all the participants of the study who actively
participated and gave their precious time. The funding for the study came
from the University Grants Commission (UGC), Nepal. The help of the
medical undergraduate students from Pokhara at Manipal College of Medical
Sciences (MCOMS) and Mr. Kishor Adhikari, Pokhara University, is greatly
acknowledged. They helped in locating wards of the study area and
collecting data. Our gratitude to Mr. Sovit Khadka, Lecturer (English), Kalika
Multiple Campus, and Mr. Phanendra Prasad Poudel, Assistant Professor,
Department of Anatomy, MCOMS, Pokhara, Nepal for their sincere
contribution in forward and backward translation of the questionnaire, and
transcription. We are thankful for the help provided by Dr. Damodar Sharma,
Lecturer, Department of Pharmacology, MCOMS, in collecting data. The
guidance of Mr. Dinesh Bhattarai, undersecretary, Central Bureau of Statistics,
Kathmandu, is greatly acknowledged. We wish to thank Ms. Asmita
Dhungana of Fulbourn Hospital, Cambridge, United Kingdom for
copyediting the manuscript.
Gyawali et al. BMC Public Health  (2015) 15:435 Page 14 of 14Author details
1Department of Pharmacology, Manipal College of Medical Sciences,
Pokhara, Nepal. 2Department of Pharmacy, L.R. Institute of Pharmacy,
Jabli-kyar, Solan, India. 3Department of Pharmacology, Xavier University
School of Medicine, Oranjestad, Aruba, Kingdom of the Netherlands.
4Department of Statistics, PN Multiple Campus, Pokhara, Nepal. 5Department
of Community Medicine, Manipal College of Medical Sciences, Pokhara,
Nepal. 6Department of Clinical Pharmacology & Therapeutics, KIST Medical
College, Imadol, Nepal.
Received: 17 July 2014 Accepted: 22 April 2015References
1. Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile
injections and the emergence of human pathogens. Lancet.
2001;358:1989–92.
2. Hutin YJF, Hauri AM, Armstrong GL. Use of injections in healthcare settings
worldwide, literature review and regional estimates. BMJ.
2000;2003(327):1075. [http://www.bmj.com/content/327/7423/1075.long]
3. Injection safety fact sheets (April 2002). [http://who.int/injection_safety/
toolbox/en/InjectionFactSheet2002.pdf]
4. Cheraghali AM, Solemani F, Behmanesh Y, Habibipour F, Ismaeilzadeh A,
Nikfar S, et al. Physicians’ attitude toward injectable medicines. J Pharmacol
Toxicol. 2006;1(1):33–9.
5. Huang N, Chou YJ, Chang HJ, Ho M, Morlock L. Antibiotic prescribing by
ambulatory care physicians for adults with nasopharyngitis, URIs, and acute
bronchitis in Taiwan: a multi-level modeling approach. Fam Pract.
2005;22:160–7.
6. Staa LVA, Hardon A. Injection practice in the developing world – Results
and Recommendations from field studies in Uganda and Indonesia. World
Health Organization (WHO): EDM Research Series N*20 (WHO/ DAP); 1996.
[http://apps.who.int/medicinedocs/pdf/s2232e/s2232e.pdf]
7. Chowdhury AKA, Roy T, Faroque ABM, Bachar SC, Asaduzzaman M, Nasrin N,
et al. A comprehensive situation assessment of injection practices in
primary health care hospitals in Bangladesh. BMC Public Health. 2011;11:779.
8. Choi KH, Park SM, Lee JH, Kwon S. Factors affecting the prescribing patterns
of antibiotics and injections. Korean Med Sci. 2012;27:120–7.
9. Janjua NZ, Hutin YJ, Akhtar S, Ahmad K. Population beliefs about the efficacy
of injections in Pakistan’s Sindh province. Public Health. 2006;120(9):824–33.
10. Gyawali S, Rathore DS, Shankar PR, KC V. Strategies and challenges for safe
injection practice in developing countries: a review. J Pharmacol Pharmco.
2013;4:8–12.
11. Simonsen L, Kane A, Lloyd J. Unsafe injections in the developing world and
transmission of blood borne pathogen: a review. Bull World Health Organ.
1999;77(10):789–800.
12. Bhattarai MD, Adhikari P, Bhattarai MD, Kane A, Uprety T, Wittet S: Rapid
assessment of perceptions, knowledge and practices related to
immunization injection safety in Nepal. General Welfare Pratisthan and
Gates Children’s vaccine Programme at PATH; 2001. [http://path.org/
vaccineresources/files/Immunization_Injection%20Safety_in_Nepal.pdf]
13. Question & Answers, Safety of injections [http://who.int/injection_safety/
about/resources/en/QuestionAndAnswersInjectionSafety.pdf]
14. The World Health Organization. Revised injection assessment tool (tool C
revised). Geneva: Switzerland; 2008. [http://who.int/injection_safety/
Injection_safety_final-web.pdf]
15. Hutin Y, Hauri A, Chiarello L, Catlin M, Stilwell B, Ghebrehiwet T, et al. best
infection control practices for intradermal, subcutaneous, and intramuscular
needle injections. Bull World Health Organ. 2003;81(7):491–500.
16. Wilburn S, Eijkemans G. Protecting health workers from occupational
exposure to HIV, hepatitis, and other blood borne pathogens: from research
to practice. Asian-Pacific Newsletter Occupational Health and Safety.
2007;14:8–12.
17. World Health Organization (WHO). WHO best practices for injections and
related procedures toolkit. Geneva, Switzerland: WHO; 2010.
18. Miller MA, Pisani E. The cost of unsafe injection. Bull World Health Organ.
1999;77:808–11.
19. Department of Health Services. Annual report F/Y 2009/10. Kathmandu:
Government of Nepal; 2011.20. Shankar PR, Partha P, Shenoy N. Self medication and non-doctor
prescription in Pokhara valley, western Nepal: a questionnaire-based
study. BMC Fam Pract. 2002;3:17.
21. Gyawali S, Rathore DS, Adhikari K, Shankar PR, KC V, Basnet S. Pharmacy
practice and injection use in community pharmacies in Pokhara city,
Western Nepal. BMC Health Serv Res. 2014;14:190.
22. District Development Committee Kaski: District profile 2010 (in Nepali
Language). Pokhara; 2010. [http://ddckaski.gov.np/alluploads/
DDC_District%20Profile%20bookindd.pdf]
23. Bhattarai MD, Wittet S: Perception About Injections And Private Sector
Injection Practices In Central Nepal. General Welfare Pratisthan And Gates
Children's Vaccine Programme At PATH; 2000. [http://path.org/
vaccineresources/files/Nepal-Inject-Practices-RA.pdf]
24. Gyawali S, Rathore DS, KC B, Shankar PR. Study of status of safe injection
practice and knowledge regarding injection safety among primary health
care workers in Baglung district, Western Nepal. BMC Int Health Hum Rights.
2013;13:3.
25. Gyawali S, Rathore DS, Shankar PR, Maskey M, KC V. Injection practices in
Nepal: Health policymakers’ perception. BMC Int Health Hum Rights. 2014;
14:21. doi:10.1186/1472-698X-14-21.
26. Central Bureau of Statistics (CBS). Nepal in Figures 2013. Nepal:
Kathmandu; 2013.
27. Ministry of Health and Population. Nepal population report. Nepal:
Kathmandu; 2011.
28. Mahajan BK. Methods in biostatistics for medical students and research
workers. 7th ed. Delhi: Jaypee Brothers Medical Publishers; 2010.
29. Safe Injection Global Network (SIGN): Advocacy booklet. Geneva; 2011.
[http://who.int/injection_safety/sign/advocacy_booklet/en/]
30. Central Bureau of Statistics (CBS). Population Census 2068: Enumerator
Manual (in Nepali). Nepal: Central Bureau of Statistics (CBS); 2011.
31. Gisselquist D, Hutin YJF. Pilot-testing the WHO tools to assess and evaluate
injection practices; A summary of 10 assessments coordinated by WHO
in seven countries (2000–2001). Geneva: World Health Organization:
WHO/BCT/03.10; 2003.
32. Thapa S, Mishra V. Mass media exposure among urban youth in Nepal.
Asia-Pac Popul J. 2003;18(1):5–28.
33. Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs.
2008;62(1):107–15.
34. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis.
Qual Health Res. 2005;15(9):1277–88.
35. IPEN Study Group. Injection practices in India. WHO South-East Asia J Public
Health. 2012;1(2):189–200.
36. Vong S, Perz JF, Sok S, Som S, Goldstein S, Hutin Y, et al. Rapid assessment
of injection practices in Cambodia, 2002. BMC Public Health. 2005;5:56.
37. Kafle KK, Madden JM, Shrestha AD, Karkee SB, Das PL, Pradhan YM, et al.
Can licensed drug sellers contribute to safe motherhood? a survey of
the treatment of pregnancy related anemia in Nepal. Soc Sci Med.
1996;42(11):1577–88.
38. Ministry of Health and Population (MoHP) in collaboration of WHO: Nepal
pharmaceutical country profile. Kathmandu; September 27, 2011. [http://
apps.who.int/medicinedocs/en/m/abstract/Js19096en/]
39. Liss GM, Crimi C, Jaczek KH, Anderson A, Slattery B, D’Cunha C. Improper
office disposal of needles and other sharps: an occupational hazard outside
of health care institutions. Can J Public Health. 1990;81(6):417–20.
40. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe
injection and the transmission of Hepatitis B and C in a periurban
community in Pakistan. Bull World Health Organ. 2000;78:956–63.
41. Altaf A, Shah SA, Shaikh K, Constable FM, Khamassi S. Lessons learned from
community based intervention to improve injection safety in Pakistan. BMC
Res Notes. 2013;6:159.
